Please try another search
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.
Name | Age | Since | Title |
---|---|---|---|
Peggy V. Phillips | 67 | 2006 | Independent Director |
Daniel L. Kisner | 74 | 2010 | Independent Director |
Julie M. Eastland | 58 | 2020 | Independent Director |
Scott D. Myers | 57 | 2021 | Independent Chairman of the Board |
Robert L. Coffman | 76 | 2000 | Member of Scientific Advisory Board |
Francis R. Cano | 78 | 2009 | Independent Director |
Stanley A. Plotkin | 90 | 2005 | Member of Scientific Advisory Board |
Miriam Merad | - | 2018 | Member of Scientific Advisory Board |
Drew Mark Pardoll | - | 2018 | Member of Scientific Advisory Board |
E. John Wherry | - | 2018 | Member of Scientific Advisory Board |
Laura Q. M. Chow | - | 2018 | Member of Scientific Advisory Board |
Peter R. Paradiso | 72 | 2020 | Chairman of the Scientific Advisory Board & Independent Director |
Rino Rappuoli | 71 | 2023 | Member of Scientific Advisory Board |
Brent MacGregor | 59 | 2020 | Independent Director |
Elaine D. Sun | 51 | 2021 | Independent Director |
Kathryn M. Edwards | - | 2023 | Member of Scientific Advisory Board |
Ryan Spencer | 46 | 2019 | CEO, Interim CFO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review